Poly Implant Prothése (PIP) Suspended From Marketing, Distribution and Exportation
Recent news reports have given light to the manufacturing standards of breast implants. Breast implants made by French company Poly Implant Prothése (PIP) have been found to contain industrial-grade silicone instead of medical-grade silicone. Approximately 300,000 women in 65 countries received implants made by the company. The PIP implants have been suspended from marketing, distribution and exportation. The health risks of industrial-grade silicone remain unclear but there are speculations of increased incidence of inflammation and concerns about cancer and other toxic exposures. PIP silicone implants were never approved and/or licensed for the use in the United States.
It is important to reiterate and stress that implants in the United States have a long, proven history of high quality with rigorous testing during the manufacturing process. Implants in the United States adhere to strict quality manufacturing requirements that measures excellent strength, resilience and elasticity. The FDA sets high standards in extensive bio-compatibility testing on all its breast implants. With these safety standards in place, the global reputation for high quality breast implants cannot be undermined.
Due to these recent developing reports on PIP implants, Dr. Jon Paul Trevisani has consulted with women who have undergone breast augmentation using these French PIP implants. Dr. Jon Paul Trevisani states, “I have performed numerous of breast augmentation and breast revisionary surgeries. These women who have received PIP implants do not compare with ruptured implants I have seen before. The shell of the PIP implants were completely ruptured and disintegrated”.
Mentor® has designed a Compassionate Care Program for patients with PIP Breast Implants who are considering replacement. The program is offering a $250 American Express® Gift Card to patients who replace PIP Saline or Gel Breast Implants with MENTOR® Saline or Gel Breast Implants. This program is valid from January 1, 2012 through December 31, 2012, and may be subject to program limits.
To learn more about this offer, please call our office at 407-901-4934 to set up your complimentary consultation with Dr. Jon Paul Trevisani.
Submitted by: Roshani J. Patel